The company's main business and industry classification are currently not specified.
Its operational identity and core defining characteristics remain undefined without further details.
Updated: February 27, 2026, 16:00 EST
Technical Perspective SN has delivered impressive intermediate-term gains, significantly outpacing the market over three months. While its high beta indicates substantial volatility and recent momentum has moderated, the stock's position below its 52-week high suggests it is not currently overbought. The technical picture points to strong performance with typical swings for a growth stock.
Fundamental Health The company shows exceptional revenue growth, though profitability margins have faced recent pressure. Its financial foundation is robust, with low debt and strong cash flow generation providing operational stability. While operational efficiency metrics like ROE are adequate, there is clear room for improvement in working capital management.
Valuation & Risk SN's valuation presents a compelling story: the extremely high TTM P/E is expected to normalize dramatically based on forward earnings projections, and a PEG ratio well below 1 suggests the stock is undervalued relative to its growth potential. The primary risk is its high volatility, but the lack of significant short interest implies market consensus is not bearish.
Investment Recommendation SN is a BUY for growth-oriented investors comfortable with volatility. The company's strong revenue expansion, solid financial health, and a forward valuation that appears attractive based on expected earnings growth create a positive outlook. While the stock's ride may be bumpy, the fundamental growth story and reasonable forward valuation justify investment for those seeking aggressive growth.
Based on the comprehensive analysis provided, here is a 12-month outlook for SN:
Key Catalysts: The primary driver for SN's potential appreciation is the anticipation of its high earnings growth translating into significantly improved profitability. The exceptionally low PEG ratio indicates the market may not be fully pricing in this robust growth trajectory, creating a potential catalyst as earnings materialize. Continued strong revenue expansion will be critical to validating the optimistic forward earnings estimates.
Potential Risks: The most significant risk is the stock's high beta and inherent volatility, which could lead to substantial price swings unrelated to company-specific news. There is also execution risk; if the company fails to meet its lofty forward earnings projections or shows further pressure on profitability margins, the high current TTM P/E could lead to a sharp downward re-rating.
Target Price Range: While a specific analyst target is not provided, the analysis suggests an upward bias. Given the "undervalued" signal from the PEG ratio below 1 and the expectation for earnings to normalize the high P/E, a price target range of $130 - $150 over the next 12 months seems reasonable, contingent on the company meeting its growth forecasts. Investors should be prepared for a volatile path toward that range.
Most Wall Street analysts are optimistic about SharkNinja, Inc.'s 12-month outlook, with consensus target around $122.87, indicating expected upside potential.
Overall, SN has investment potential but also faces challenges. Here are key factors to weigh before investing.
SN demonstrates exceptionally strong intermediate-term performance despite recent moderation.
The stock has posted robust 39.31% gains over three months, significantly outperforming the market by 35.28%, though its 1-month return of 1.73% suggests recent momentum has tempered. With a beta of 1.356, the stock's high volatility has contributed to these amplified returns but also indicates elevated risk.
Currently trading at $121.91, SN sits in the upper quartile of its 52-week range ($60.50-$133.99), approximately 88% above its low but still 9% below its high. The substantial 1-year maximum drawdown of -37.54% highlights the stock's volatile nature but does not currently suggest an overbought condition given the distance from recent highs.
| Period | SN Return | S&P 500 |
|---|---|---|
| 1m | +2.5% | -1.4% |
| 3m | +40.4% | +4.1% |
| 6m | +2.7% | +7.5% |
| 1y | +16.9% | +15.4% |
| ytd | +7.9% | +0.4% |
Revenue & Profitability SN demonstrates strong revenue growth with Q4 revenue reaching $2.1 billion, up 29% from Q3's $1.63 billion. However, profitability metrics softened as the gross profit margin declined from 49.8% to 47.9%, while the net profit margin decreased from 11.6% to 12.1%, indicating some pressure on cost management despite top-line expansion.
Financial Health The company maintains a solid balance sheet with a low debt-to-equity ratio of 0.38 and a robust interest coverage ratio of 36.5, reflecting minimal liquidity risk. Strong cash flow is evidenced by an operating cash flow to sales ratio of 27.9%, supporting healthy operational funding and financial flexibility.
Operational Efficiency SN shows moderate operational efficiency with an ROE of 9.5% and an asset turnover of 0.39, suggesting adequate but not exceptional utilization of assets. The cash conversion cycle of 98 days highlights room for improvement in working capital management, though fixed asset turnover of 5.6 indicates efficient use of long-term assets.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardBased on the significant disparity between the trailing twelve months (TTM) P/E of 210.18 and the forward P/E of 15.47, the stock appears to be transitioning from a period of extremely high valuation to a more normalized level. The forward P/E suggests the market is pricing in substantial earnings growth for the current fiscal year. Furthermore, the PEG ratio of 0.44, which is well below 1.0, strongly indicates that the stock is fundamentally undervalued relative to its expected earnings growth rate.
Due to the unavailability of industry average data, a direct peer comparison for P/E, P/B, or EV/EBITDA cannot be conducted. However, the forward P/E of 15.5 and the PEG ratio below 1.0 generally suggest a reasonable to attractive valuation profile on an absolute basis. The notably high P/B and EV/EBITDA ratios highlight that the company's assets and current operational earnings are highly valued by the market, which may be justified by strong growth prospects or intangible asset value.
Volatility risk appears elevated, as evidenced by a beta of 1.356, indicating the stock is approximately 36% more volatile than the broader market. This heightened sensitivity is corroborated by the significant one-year maximum drawdown of -37.54%, demonstrating substantial downside price swings during market stress.
The absence of short interest suggests the market currently holds a neutral-to-bullish consensus, which eliminates the risk of a short squeeze but also provides no contrary opinion to temper bullish exuberance. While the lack of reported short interest typically implies adequate liquidity, it does not mitigate broader macroeconomic or company-specific operational risks.
Bullish. SN offers strong growth potential with a reasonable forward P/E of 15.5, a compelling PEG ratio of 0.44 indicating undervaluation relative to growth, and solid revenue expansion. This stock is suitable for growth-oriented investors comfortable with higher volatility, given its beta of 1.36 and substantial price swings.
SN appears undervalued based on its forward-looking metrics. The stock trades at a forward P/E of 15.5 and a PEG ratio of 0.44, both of which are attractive levels indicating the price is low relative to expected earnings growth. Although profitability is softening, the market seems to be undervaluing SN's strong revenue growth (29% in Q4) and solid financial health, pricing it for significant future earnings expansion that the current PEG ratio suggests is not yet fully reflected in the stock price.
Based on the provided information, here are the key risks of holding SN, ordered by importance:
1. Elevated Volatility Risk: The stock's high beta of 1.356 makes it significantly more volatile than the market, exposing it to larger price swings, as evidenced by its substantial -37.54% maximum drawdown. 2. Profitability Pressure Risk: Despite strong revenue growth, the company faces margin compression, as indicated by the declining gross profit margin, which could threaten future earnings if cost pressures persist. 3. Operational Efficiency Risk: An asset turnover of 0.39 and a cash conversion cycle of 98 days suggest potential inefficiencies in utilizing assets and managing working capital, which could hinder profitability and cash flow generation.
Based on the provided analysis, my forecast for SN stock through 2026 is as follows.
My base case target price for late 2026 is in the range of $160 - $180, with a bull case of up to $200+ if the company successfully executes on its growth trajectory. Key growth drivers include the continuation of its strong revenue expansion (29% QoQ in Q4) and the anticipated normalization of its high P/E ratio as projected earnings growth materializes. The primary assumptions are that SN maintains revenue growth above 20% annually and improves its net profit margins from the current ~12% level. This forecast is highly uncertain and heavily dependent on the company's ability to manage costs and deliver on its earnings potential amidst its noted high volatility.